| CAR T cells: continuation in a revolution of immunotherapy AK Singh, JP McGuirk The Lancet Oncology 21 (3), e168-e178, 2020 | 301 | 2020 |
| Allogeneic Stem Cell Transplantation: A Historical and Scientific Overview AK Singh, JP McGuirk Cancer Research 76 (22), 6445-6451, 2016 | 265 | 2016 |
| Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission A Rashidi, M Hamadani, MJ Zhang, HL Wang, H Abdel-Azim, M Aljurf, ... Blood advances 3 (12), 1826-1836, 2019 | 131 | 2019 |
| Fatal GvHD induced by PD-1 inhibitor pembrolizumab in a patient with Hodgkin’s lymphoma AK Singh, LF Porrata, O Aljitawi, T Lin, L Shune, S Ganguly, JP McGuirk, ... Bone marrow transplantation 51 (9), 1268-1270, 2016 | 80 | 2016 |
| Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma RW Merryman, L Castagna, L Giordano, VT Ho, P Corradini, A Guidetti, ... Leukemia, 1-12, 2021 | 71 | 2021 |
| Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients MU Mushtaq, M Shahzad, SG Chaudhary, M Luder, N Ahmed, ... Transplantation and Cellular Therapy 27 (9), 796. e1-796. e7, 2021 | 57 | 2021 |
| Erythropoietin modulation is associated with improved homing and engraftment after umbilical cord blood transplantation OS Aljitawi, S Paul, A Ganguly, TL Lin, S Ganguly, G Vielhauer, ... Blood, The Journal of the American Society of Hematology 128 (25), 3000-3010, 2016 | 47 | 2016 |
| Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma RW Merryman, RA Redd, T Nishihori, J Chavez, Y Nieto, JM Darrah, ... Blood Advances 5 (6), 1648-1659, 2021 | 41 | 2021 |
| A phase I study to evaluate two doses of Wharton’s jelly-derived mesenchymal stromal cells for the treatment of de novo high-risk or steroid-refractory acute graft versus host … RP Soder, B Dawn, ML Weiss, N Dunavin, S Weir, J Mitchell, M Li, ... Stem Cell Reviews and Reports 16 (5), 979-991, 2020 | 40 | 2020 |
| Effect of extracorporeal photopheresis on lung function decline for severe bronchiolitis obliterans syndrome following allogeneic stem cell transplantation KR Brownback, SQ Simpson, LR Pitts, D Polineni, JP McGuirk, S Ganguly, ... Journal of clinical apheresis 31 (4), 347-352, 2016 | 34 | 2016 |
| Post-transplantation cyclophosphamide is associated with an increase in non-cytomegalovirus herpesvirus infections in patients with acute leukemia and myelodysplastic syndrome A Singh, CE Dandoy, M Chen, S Kim, CM Mulroney, MA Kharfan-Dabaja, ... Transplantation and cellular therapy 28 (1), 48. e1-48. e10, 2022 | 33 | 2022 |
| Outcomes with CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis M Shahzad, RS Siddiqui, I Anwar, SG Chaudhary, T Ali, M Naseem, ... Transplantation and Cellular Therapy, 2021 | 33 | 2021 |
| Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation A Britt, GR Mohyuddin, B McClune, A Singh, T Lin, S Ganguly, ... Leukemia Research 95, 106402, 2020 | 22 | 2020 |
| Incidence and impact of community respiratory viral infections in post‐transplant cyclophosphamide‐based graft‐versus‐host disease prophylaxis and … CM Mulroney, M Bilal Abid, A Bashey, RF Chemaly, SO Ciurea, M Chen, ... British Journal of Haematology, 2021 | 20 | 2021 |
| Evaluation of performance status and hematopoietic cell transplantation specific comorbidity index on unplanned admission rates in patients with multiple myeloma undergoing … C Obiozor, DP Subramaniam, C Divine, L Shune, AK Singh, TL Lin, ... Biology of Blood and Marrow Transplantation 23 (10), 1641-1645, 2017 | 16 | 2017 |
| Retrospective evaluation of fidaxomicin versus oral vancomycin for treatment of Clostridium difficile infections in allogeneic stem cell transplant L Prohaska, Z Mahmoudjafari, L Shune, A Singh, T Lin, S Abhyankar, ... Hematology/oncology and stem cell therapy 11 (4), 233-240, 2018 | 14 | 2018 |
| Safety and efficacy of allogeneic hematopoietic stem cell transplant after programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) blockade for classical Hodgkin … RW Merryman, L Castagna, P Corradini, VT Ho, DA Bond, S Jaglowski, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | 11 | 2019 |
| Epstein-Barr viremia and post-transplant lymphoproliferative disorders in patients undergoing haploidentical stem cell transplantation with post-transplant cyclophosphamide GR Mohyuddin, J Roller, L Shune, T Lin, A Dias, S Ganguly, S Abhyankar, ... Hematology/oncology and stem cell therapy 12 (3), 171-173, 2019 | 9 | 2019 |
| Results of the first clinical study in humans that combines hyperbaric oxygen pretreatment with autologous peripheral blood stem cell transplantation H Abdelhakim, L Shune, S Bhatti, AR Cantilena, A Baran, TL Lin, ... Biology of Blood and Marrow Transplantation 25 (9), 1713-1719, 2019 | 9 | 2019 |
| Outcomes for newly diagnosed patients with acute myeloid leukemia dosed on actual or adjusted body weight WM Bray, C Bivona, M Rockey, D Henry, D Grauer, S Abhyankar, ... Cancer chemotherapy and pharmacology 76 (4), 691-697, 2015 | 9 | 2015 |